publication venue for
- New antithrombotic strategies: Lessens from clinical trials with glycoprotein IIb/IIIa antagonists and direct thrombin inhibitors 1997
- Pathophysiology and management of patients with acute ischaemic syndromes: Some perspectives 1997
- Angiotensin-converting enzyme inhibitors as a new frontier in cardiovascular prevention: Results of the HOPE trial. 7-7. 2001
- Diabetes and the HOPE study: implications for macrovascular and microvascular disease.. 8-12. 2001
- Modifying the natural history of atherosclerosis: the SECURE trial.. 13-18. 2001
- Emerging approaches in the prevention of atherosclerotic cardiovascular diseases.. 94:7-19. 1998
- The global problem of cardiovascular disease.. 94:3-6. 1998
- Prevention of venous thrombosis in patients undergoing major orthopaedic surgical procedures.. 65:2-8. 1989
- The relationship between ex vivo anti-factor Xa levels and efficacy/safety of low molecular weight heparin.. 65:18-23. 1989